U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT05774548) titled 'LA PrEP Impact and Cost-effectiveness (TEAMS)' on Feb. 22.
Brief Summary: This study will have three components:
* Discrete choice experiments
* Analysis of routine service data
* Impact and cost-effectiveness analyses using results from 1 and 2
Study Type: Interventional
Condition: Hiv
Intervention: * Other: In-depth interviews (IDI)
In-depth interviews (IDI) 20 MSM,20 TGW, current, previous PrEP users will assess which attributes are relevant each population. Posters will be used to recruit for IDIs. Self-reported HIV-negative who either report interest in current or past PrEP use will be eligible to participate in IDI. ID...